An advanced personal nasal sampler (PNS) to assess occupational exposures to airborne viruses
先进的个人鼻腔采样器 (PNS),用于评估空气传播病毒的职业暴露
基本信息
- 批准号:10709618
- 负责人:
- 金额:$ 23.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2024-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
An advanced personal nasal sampler (PNS) to assess occupational exposures to
airborne viruses
This grant application responds to PAR-18-798: NIOSH Exploratory and/or Developmental Grant Program (R21).
Exposure to airborne viruses, such as SARS-CoV-2 and others in a workplace is a major concern worldwide,
and new tools are needed to determine the actual personal exposures. Personal samplers typically require
cumbersome external sampling components, such as pumps and tubing. We propose to develop a personal
nasal sampler (PNS): a device that utilizes a person’s own breathing and an advanced filter medium to measure
actual personal exposures to airborne infectious agents, including viruses and virus-laden droplets. We
hypothesize that the proposed PNS will have a collection efficiency of >90% for a broad range of particle sizes
(from viruses to virus-particle agglomerates) and low airflow resistance. It will not need any external components.
PNS will consist of a novel hybrid filter installed in a medical-grade 3D-printed container. The PNS will be
worn at the anterior tip of a person’s nostrils and act as a personal sampler of airborne particles. The hybrid filter
will be designed by coating several candidate base substrates with nanofibers produced from permanently
polarized substances, such as ferroelectric polyvinylidene fluoride [PVDF or P(VDF-TrFE)]. The PNS’s
performance will be tested in a laboratory with polydisperse particles (e.g., sodium chloride) and inactivated
human coronavirus OC43. We will also develop and optimize an effective protocol to elute viral particles captured
by the PNS. PNS will also be tested in the hospital triage area, where it will be affixed to a mannequin’s nostrils;
the amount of viral RNA captured by the PNS will be compared with that captured by a reference sampler. The
PNS will be operated at sampling flow rates of 30-85 L/min. The field testing will be used to prepare us for future
studies with volunteer workers to assess their exposure to infectious viral particles during work activities.
The proposal’s goal responds to NIOSH’s COVID-19 Research Agenda calling to understand SARS-CoV-2
exposure in workplace settings. It also responds to NIOSH Strategic Plan’s “Immune, Infectious, and Dermal
Disease Prevention” cross-sector and sectors of National Agriculture, Forestry, and Fishing; Healthcare;
Services; Transportation, Warehousing, and Utilities.
This proposal responds to the NIOSH r2P initiative by developing an innovative tool that will determine
actual personal exposures to airborne viral agents, thus leading to worker health protection. The new personal
sampling technology will eventually be transferred into the workplace.
The output of the study will be a prototype PNS for determining personal exposures to respiratory agents in
occupational environments. We expect that intermediate outcomes will include a patent, citations in the
literature, and, finally, the adaptation of sampler in work environments. The end outcome is expected to be a
better understanding of personal exposures to respiratory viruses, eventually leading to steps minimizing such
exposures and improving worker health outcomes.
一种用于评估职业暴露的高级个人鼻采样器(PNS)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Taewon T Han其他文献
Taewon T Han的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Taewon T Han', 18)}}的其他基金
An advanced personal nasal sampler (PNS) to assess occupational exposures to airborne viruses
先进的个人鼻腔采样器 (PNS),用于评估空气传播病毒的职业暴露
- 批准号:
10432372 - 财政年份:2022
- 资助金额:
$ 23.09万 - 项目类别:
Advanced Sampler for Assessing Exposure to Biological Aerosols
用于评估生物气溶胶暴露情况的高级采样器
- 批准号:
9105970 - 财政年份:2016
- 资助金额:
$ 23.09万 - 项目类别:
Personal Electrostatic Bioaerosol Sampler (PEBS) with High Sampling Flow Rate
具有高采样流量的个人静电生物气溶胶采样器 (PEBS)
- 批准号:
8770891 - 财政年份:2014
- 资助金额:
$ 23.09万 - 项目类别:
Personal Electrostatic Bioaerosol Sampler (PEBS) with High Sampling Flow Rate
具有高采样流量的个人静电生物气溶胶采样器 (PEBS)
- 批准号:
8917802 - 财政年份:2014
- 资助金额:
$ 23.09万 - 项目类别:
相似国自然基金
基于量子点多色荧光细胞标志谱型的CTC鉴别与肿瘤个体化诊治的研究
- 批准号:30772507
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Novel Peptide Immunomodulators for Treating Sepsis
用于治疗脓毒症的新型肽免疫调节剂
- 批准号:
10602761 - 财政年份:2023
- 资助金额:
$ 23.09万 - 项目类别:
An advanced personal nasal sampler (PNS) to assess occupational exposures to airborne viruses
先进的个人鼻腔采样器 (PNS),用于评估空气传播病毒的职业暴露
- 批准号:
10432372 - 财政年份:2022
- 资助金额:
$ 23.09万 - 项目类别:
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
指导艾滋病毒/药物滥用研究的先进移动医疗技术和机器学习
- 批准号:
10668451 - 财政年份:2021
- 资助金额:
$ 23.09万 - 项目类别:
Leica STELLARIS 5 Confocal Microscope
Leica STELLARIS 5 共焦显微镜
- 批准号:
10177189 - 财政年份:2021
- 资助金额:
$ 23.09万 - 项目类别:
Mentoring in Advanced mHealth Technologies and Machine Learning for HIV/Drug Abuse Research
指导艾滋病毒/药物滥用研究的先进移动医疗技术和机器学习
- 批准号:
10469618 - 财政年份:2021
- 资助金额:
$ 23.09万 - 项目类别:
Puipuia le Ola: Increasing reach and uptake of COVID-19 testing among Pacific Islanders in Hawaii and Guam
Puipuia le Ola:在夏威夷和关岛的太平洋岛民中扩大 COVID-19 检测的覆盖范围和接受度
- 批准号:
10259631 - 财政年份:2020
- 资助金额:
$ 23.09万 - 项目类别:
Personal Protective Equipment for Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies
用于 COVID-19 相关疫苗和治疗临床试验和临床研究资源的个人防护装备
- 批准号:
10252679 - 财政年份:2020
- 资助金额:
$ 23.09万 - 项目类别:
Vanderbilt CTU SARS-CoV-2 Supplement
范德比尔特 CTU SARS-CoV-2 补充品
- 批准号:
10166023 - 财政年份:2020
- 资助金额:
$ 23.09万 - 项目类别: